metronidazole
(me troe ni' da zole)
Apo-Metronidazole (CAN), Flagyl, Flagyl 375, Flagyl ER, Flagyl IV, Flagyl IV RTU, MetroGel, MetroGel-Vaginal, NidaGel (CAN),Noritate, Protostat
Pregnancy Category B
Drug classes
Antibiotic
Antibacterial
Amebicide
Antiprotozoal
Therapeutic actions
Bactericidal: Inhibits DNA synthesis in specific (obligate) anaerobes, causing cell death; antiprotozoal-trichomonacidal, amebicidal: Biochemical mechanism of action is not known.
Indications
· Acute infection with susceptible anaerobic bacteria
· Acute intestinal amebiasis
· Amebic liver abscess
· Trichomoniasis (acute and partners of patients with acute infection)
· Preoperative, intraoperative, postoperative prophylaxis for patients undergoing colorectal surgery
· Topical application: Treatment of inflammatory papules, pustules, and erythema of rosacea
· Unlabeled uses: Prophylaxis for patients undergoing gynecologic, abdominal surgery; hepatic encephalopathy; Crohn's disease; antibiotic-associatedpseudomembranous colitis; treatment of Gardnerella vaginalis, giardiasis (use recommended by the CDC)
Contraindications and cautions
· Contraindicated with hypersensitivity to metronidazole; pregnancy (do not use for trichomoniasis in first trimester).
· Use cautiously with CNS diseases, hepatic disease, candidiasis (moniliasis), blood dyscrasias, lactation.
Available forms
Tablets—250, 500 mg; ER tablets—750 mg; capsules—375 mg; powder for injection—500 mg; injection—500 mg/100 mL; lotion, cream, gel—0.75%; cream—1%; vaginal gel—0.75%
Dosages
ADULTS
Oral
· Amebiasis: 750 mg/tid PO for 5–10 days. (In amebic dysentery, combine with iodoquinol 650 mg PO tid for 20 days.)
· Antibiotic-associated pseudomembranous colitis: 1–2 g/day PO for 7–10 days.
· Gardnerella vaginalis: 500 mg bid PO for 7 days.
· Giardiasis: 250 mg tid PO for 7 days.
· Trichomoniasis: 2 g PO in 1 day (1-day treatment) or 250 mg tid PO for 7 days.
IV
· Anaerobic bacterial infection: 15 mg/kg IV infused over 1 hr; then 7.5 mg/kg infused over 1 hr q 6 hr for 7–10 days, not to exceed 4 g/day.
· Prophylaxis: 15 mg/kg infused IV over 30–60 min and completed about 1 hr before surgery. Then 7.5 mg/kg infused over 30–60 min at 6- to 12-hr intervals after initial dose during the day of surgery only.
Topical (MetroGel)
· Treatment of inflammatory papules, pustules, and erythema of rosacea: Apply and rub in a thin film twice daily, morning and evening, to entire affected areas after washing; results should be seen within 3 wk; treatment through 9 wk has been effective.
Vaginal (MetroGel-Vaginal)
· In non-pregnant women: 1 applicatorful intravaginally one to two times/day for 5 days.
PEDIATRIC PATIENTS
· Anaerobic bacterial infection: Not recommended.
· Amebiasis: 35–50 mg/kg/day PO in three doses for 10 days.
Pharmacokinetics
Route | Onset | Peak |
Oral | Varies | 1–2 hr |
IV | Rapid | 1–2 hr |
Metabolism: Hepatic; T1/2: 6–8 hr
Distribution: Crosses placenta; enters breast milk
Excretion: Feces, urine
IV facts
Preparation: Reconstitute by adding 4.4 mL of sterile water for injection, bacteriostatic water for injection, 0.9% sodium chloride injection, bacteriostatic 0.9% sodium chloride injection to the vial and mix thoroughly. Resultant volume is 5 mL with a concentration of 100 mg/mL. Solution should be clear to pale yellow to yellow-green; do not use if cloudy or if containing precipitates; use within 24 hr; protect from light. Add reconstituted solution to glass or plastic container containing 0.9% sodium chloride injection, 5% dextrose injection or lactated Ringer's; discontinue other solutions while running metronidazole.
Infusion: Before administration, add 5 mEq sodium bicarbonate injection for each 500 mg used (if not using premixed bags); mix thoroughly. Do not refrigerate neutralized solution. Do not administer solution that has not been neutralized. Infuse over 1 hr.
Adverse effects
· CNS: Headache, dizziness, ataxia, vertigo, incoordination, insomnia, seizures, peripheral neuropathy, fatigue
· GI: Unpleasant metallic taste, anorexia, nausea, vomiting, diarrhea, GI upset, cramps
· GU: Dysuria, incontinence, darkening of the urine
· Local: Thrombophlebitis (IV); redness, burning, dryness, and skin irritation (topical)
· Other: Severe, disulfiram-like interaction with alcohol, candidiasis (superinfection)
Interactions
Drug-drug
· Decreased effectiveness with barbiturates
· Disulfiram-like reaction (flushing, tachycardia, nausea, vomiting) with alcohol
· Psychosis if taken with disulfiram
· Increased bleeding tendencies with oral anticoagulants
Drug-lab test
· Falsely low (or zero) values in AST, ALT, LDH, triglycerides, hexokinase glucose tests
Nursing considerations
Assessment
· History: CNS or hepatic disease; candidiasis (moniliasis); blood dyscrasias; pregnancy; lactation
· Physical: Reflexes, affect; skin lesions, color (with topical application); abdominal examination, liver palpation; urinalysis, CBC, LFTs
Interventions
· WARNING: Avoid use unless necessary. Metronidazole is carcinogenic in some rodents.
· Administer oral doses with food.
· Apply topically (MetroGel) after cleansing the area. Advise patient that cosmetics may be used over the area after application.
· Reduce dosage in hepatic disease.
Teaching points
· Take full course of drug therapy; take the drug with food if GI upset occurs.
· Do not drink alcohol (beverages or preparations containing alcohol, cough syrups); severe reactions may occur.
· Your urine may appear dark; this is expected.
· Refrain from sexual intercourse during treatment for trichomoniasis unless partner wears a condom.
· Apply the topical preparation by cleansing the area and then rubbing a thin film into the affected area. Avoid contact with the eyes. Cosmetics may be applied to the area after application.
· You may experience these side effects: Dry mouth with strange metallic taste (frequent mouth care, sucking sugarless candies may help); nausea, vomiting, diarrhea (eat frequent small meals).
· Report severe GI upset, dizziness, unusual fatigue or weakness, fever, chills.
Adverse effects in Italic are most common; those in Bold are life-threatening.
0 comments:
Post a Comment